A scoping review of eating disorder symptoms and mental health during the postpartum period: predictors, course, and consequences for mothers and infants
Abstract
Objective: Eating disorders (ED) are most prevalent in women of reproductive age. EDs affect fertility, maternal BMI, and obstetric outcomes. During the early postpartum period, women with an ED history are at high risk for relapse. However, research on the impact of ED on maternal and infant health and development during the first postpartum year is limited. This scoping review provides an overview of the current research on postpartum ED symptoms and their effects on mothers and their babies as well as limitations of current postpartum screening practices.
Methods: This scoping review was conducted in accordance with JBI Scoping Review Methodology. It included all available English-language literature published between 2000 and January 2025 that was available on PubMed, SCOPUS, and APA PsycInfo electronic databases. We included peer-reviewed empirical manuscripts that measured maternal ED symptoms or diagnoses and that had outcomes on maternal mental health, infant development, or infant feeding interactions during the first year postpartum.
Results: Of 332 citations identified in the initial search, 43 articles were included in the review. The majority were conducted in North American and European countries. Several longitudinal studies found an increase in ED symptoms after childbirth, particularly among women with a lifetime history of EDs; compared to women with no history, women with a history of ED symptoms had elevated anxiety and depression during the postpartum…
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.